How to register and import a pharmaceutical product into Nigeria through NAFDAC.

Nigeria is one of the largest pharmaceutical markets in Africa and one of the most documentation-exacting. The regulator, the National Agency for Food and Drug Administration and Control (NAFDAC), lets no drug be imported, sold or distributed in the country until it is registered. For an overseas supplier that means the deal is not won on price, it is won on whether your importer can clear two gates cleanly. This is how those gates work, in the order a real file moves through them.

Why every drug entering Nigeria runs through NAFDAC.

NAFDAC is the gatekeeper. Under its product-registration mandate, no regulated product, drugs included, may be manufactured, imported, advertised, sold or distributed in Nigeria until it carries a NAFDAC registration. Applications are filed on NAFDAC's NAPAMS portal (the NAFDAC Automated Product Administration and Monitoring System).

There are two tracks the buyer must clear, and confusing them is the most common early mistake. The first is a one-time product registration: the approval that lets a product legally exist on the Nigerian market. The second is per-shipment import clearance: the Form M, the NAFDAC import permit and the Pre-Arrival Assessment Report that go into each port-clearance file. A product can be fully registered and a specific shipment still held at the port if the import-clearance chain is not in order. This guide covers both, registration first.

Who holds the registration: the Nigerian applicant.

The fact that organises everything else: NAFDAC's registration guideline asks the applicant for evidence of incorporation with the Corporate Affairs Commission in Nigeria, and the registration certificate is issued to that applicant. In practice the registration is therefore held by a Nigerian-incorporated company acting for the manufacturer, not by the factory abroad. Where the applicant does not own the brand, NAFDAC asks for a Power of Attorney issued by the manufacturer and notarised in the country of manufacture; where the applicant owns the brand, it asks for a Contract Manufacturing Agreement instead.

On top of that, the Nigerian importer must be properly licensed to handle medicines. The Pharmacy Council of Nigeria (PCN) registers pharmaceutical premises, including wholesale, distribution and importation pharmacies, and NAFDAC's registration guideline asks for the superintendent pharmacist's annual licence to practise and evidence of a valid premises retention licence. So the applicant is a Nigerian company with PCN-registered premises and a superintendent pharmacist, and the foreign supplier sits behind it as the source of evidence.

This is exactly where a merchant exporter who is not the manufacturer plugs in. M Care Exports does not register in Nigeria in its own name and does not pretend to. We source and authenticate the manufacturer's evidence pack and hand it to your Nigerian importer so they can file. The registration is theirs; our job is to make sure the file is clean before it is submitted.

The dossier: CTD, CoPP and the GMP evidence pack.

NAFDAC's guideline refers to the Common Technical Document (CTD) format (for example for bioequivalence data) and to a Dossier Submission Guide, so build a CTD dossier and confirm the current guide with NAFDAC. For human-use drugs, dossier screening clearance is a prerequisite, and the application is then processed on NAPAMS, with a separate application form for each product. The gating quality document inside it is the Certificate of Pharmaceutical Product (CoPP) in WHO format, issued by the health or regulatory body in the country of manufacture and authenticated by the Nigerian Embassy or High Commission in the country of origin (where no Nigerian Embassy exists, a Commonwealth or ECOWAS country can authenticate).

Around the CoPP sits the rest of the evidence pack: a Manufacturer's Certificate confirming the product is licensed for sale where it is made, a batch Certificate of Analysis on the testing laboratory's letterhead, a current GMP certificate (valid at the time of submission and authenticated like the CoPP), a Power of Attorney notarised in the country of manufacture (or a Contract Manufacturing Agreement where the applicant owns the brand), a trademark certificate registered under Class 5 (pharmaceuticals), and the product label artwork. Our WHO-GMP and CDSCO documentation guide covers how that certificate chain is produced on the Indian side.

The GMP inspection invitation and site evidence.

NAFDAC asks for more than a GMP certificate. Every application includes a letter of invitation, written by the manufacturer, to inspect the factory abroad, giving the factory's full location address (not the administrative office address) and the local agent's details. Approval depends on satisfactory GMP of the production facility, and NAFDAC points applicants to the Drug Evaluation and Research (DER) Directorate section of its website for information on the inspection of manufacturing facilities. NAFDAC's May 2025 strategic plan for foreign manufacturers describes a risk-based approach in which foreign facilities are categorised as low, medium or high risk, and that categorisation guides the scheduling of foreign GMP inspections. Whether and when your site is visited therefore depends on that scheduling, so ask NAFDAC's DER Directorate how your site will be handled, and take any inspection charge from the NAFDAC Tariff rather than from a guide.

Approval follows satisfactory dossier review, satisfactory GMP of the production facility and, where applicable, satisfactory laboratory analysis, at a meeting of NAFDAC's Food and Drug Registration Committee (FDRC). NAFDAC's May 2025 strategic plan also says it has a policy on regulatory reliance that allows it to rely on GMP assessment reports from recognised national regulatory authorities, WHO Listed Authorities and the WHO Collaborative Registration Procedure; ask NAFDAC whether it can apply to your site.

Samples, lab analysis and the import permit.

Before the product is registered, NAFDAC may need to test it (laboratory analysis applies where applicable), and bringing the test samples in is its own step. After a satisfactory NAFDAC review of the submitted documents and label, it issues a permit to import registration samples. The applicant then submits the samples with a letter, evidence of payment of the processing fee, the certificate of analysis and a copy of that permit. This sample import permit is preliminary and is not the product approval, a distinction that trips up first-time importers who assume the permit to bring samples in is the registration itself.

Where laboratory analysis applies, the result joins the dossier review and the GMP outcome in front of the FDRC. A clean, in-specification analysis on samples that match the dossier is what keeps this stage short.

Timelines and validity: what the file really takes.

NAFDAC's registration guideline sets a timeline of 240 working days from acceptance of submissions to issue of the registration number. That is the figure to plan against: 240 working days is close to a calendar year, and the guideline says the clock stops once compliances are issued. An applicant who does not respond to NAFDAC's queries within 90 working days has the application closed automatically.

Once granted, the Certificate of Registration is valid for five years and must be renewed on expiry. NAFDAC's renewal guideline asks for the renewal application to be initiated not later than six months before expiry, with a PSUR submitted to its Pharmacovigilance Directorate, and says the GMP status of the manufacturing facility will be considered before renewal. The lesson for a buyer is to plan against NAFDAC's 240 working days and to protect the timeline by submitting a complete file, so that compliance directives and queries do not hold the file.

From approval to port: Form M, PAAR and the import permit.

Registration lets the product exist on the market; it does not, by itself, clear a container. NAFDAC's port-clearance guideline (PID-GDL-004-01, effective 24 September 2022) asks the importer to submit the clearance request on NAFDAC's PIDCARMS portal with a current NAFDAC import permit, the Form M, the PAAR and, where applicable, evidence of the product's NAFDAC registration.

The Central Bank of Nigeria's Foreign Exchange Manual (4th Edition) says anyone importing physical goods must first process Form M through an Authorised Dealer Bank, irrespective of the value and whether or not payment is involved, and that the importer advises the supplier to arrange shipment upon registration of the Form M by the Nigeria Customs Service. The Nigeria Customs Service issues the Pre-Arrival Assessment Report (PAAR) used for goods clearance. At the port, NAFDAC's Ports Inspection Directorate vets the uploaded documents, which also include the manufacturer's certificate of analysis, a Clean Report of Inspection and Analysis (CRIA) where applicable, and the importer's PCN premises registration and pharmacist's annual licence. It then notifies the importer to proceed to physical inspection, draws samples for laboratory analysis, and releases the consignment on satisfactory verification; NAFDAC issues a compliance directive for any deficiency in documentation, and a consignment with an unsatisfactory laboratory result is placed on hold. For Indian supply, plan on needing a CRIA: the current port guideline says only 'where applicable', but NAFDAC's May 2025 strategic plan continues the CRIA scheme for India and China, with agents carrying out pre-shipment inspection and requiring a valid GMP certificate before authorising export, so confirm the agent and timing with NAFDAC's Ports Inspection Directorate before you book freight.

Why NAFDAC files stall, and how a merchant exporter de-risks them.

Most delays are not mysterious. The recurring causes are an incomplete or non-CTD dossier; a missing, expired or un-authenticated CoPP; and labelling artwork that does not meet NAFDAC convention. Nigerian labelling expects the generic and brand name, the manufacturer's name and full location address, provision for the NAFDAC registration number, and batch, manufacturing and expiry details, and a label in a foreign language needs an English translation on the label and the leaflet.

This is the part of the job a capable exporter absorbs. M Care's role is to source, verify and assemble the manufacturer's GMP certificate, CoPP, CTD dossier, Certificate of Analysis, samples and compliant artwork into one inspection-ready set, so the Nigerian importer files on NAPAMS without the gaps that trigger a compliance directive and reset the clock. We treat the registration as the importer's, and the clean evidence pack behind it as ours.

Cold chain for temperature-sensitive lines: what this guide covers.

For vaccines, biologics and other temperature-sensitive products, Nigeria's heat makes cold chain a compliance question, not just a logistics one. NAFDAC's registration guideline lists storage conditions among the minimum label requirements. We recommend a continuously monitored, documented cold chain so you can show the labelled conditions were kept in transit. This guide does not set out NAFDAC's separate storage and distribution rules for vaccines and biologics, so confirm the current requirements with the regulator before shipping.

In practice that means qualified packaging, data loggers on the consignment, GDP-compliant freight and an unbroken documentation trail from the Indian cold room to the Nigerian warehouse. Our cold-chain validation service and the West Africa cold-chain field note cover how that lane is run into the region.

FAQ

Does a foreign manufacturer or Indian exporter register a drug with NAFDAC directly?

In practice the application is made through a Nigerian-incorporated company, because NAFDAC asks the applicant for evidence of incorporation with the Corporate Affairs Commission in Nigeria. Where the applicant does not own the brand, NAFDAC asks for a Power of Attorney issued by the manufacturer and notarised in the country of manufacture. The applicant must also provide the superintendent pharmacist's annual licence from the Pharmacy Council of Nigeria (PCN) and evidence of a valid premises retention licence.

What is the CoPP and why does NAFDAC require it?

The Certificate of Pharmaceutical Product (CoPP) is a WHO-format certificate issued by the health or regulatory body in the country of manufacture, confirming that the sale of the product does not contravene the drug laws of that country. NAFDAC requires a CoPP for imported drugs, and it must be authenticated by the Nigerian Embassy or High Commission in the country of origin.

Does NAFDAC inspect the overseas manufacturing factory?

NAFDAC's registration guideline makes satisfactory GMP of the production facility a condition of approval, and every application includes the manufacturer's letter inviting NAFDAC to inspect the factory abroad. Under NAFDAC's May 2025 strategic plan, foreign facilities are categorised by risk to guide the scheduling of GMP inspections, so ask NAFDAC's Drug Evaluation and Research Directorate how your site will be handled and what the NAFDAC Tariff charges.

How long does NAFDAC drug registration take?

NAFDAC's guideline gives 240 working days from acceptance of submissions to issue of the registration number, and says the clock stops once compliances are issued. Queries must be answered within 90 working days, or the application is closed automatically.

How long is a NAFDAC registration valid?

A NAFDAC Certificate of Registration is valid for five years and must be renewed on expiry. NAFDAC's renewal guideline asks for the application at least six months before expiry, with a PSUR, and considers the GMP status of the manufacturing facility before renewing.

What is the difference between NAFDAC registration and the import permit or Form M?

They are separate. Product registration is the one-time approval that lets a product exist in the Nigerian market. To bring registration samples in beforehand NAFDAC issues a separate permit to import registration samples. For port clearance, NAFDAC's port guideline then asks for a current NAFDAC import permit together with the Form M, which the Central Bank of Nigeria requires to be processed through an Authorised Dealer Bank for any import of physical goods. Nigeria Customs issues a Pre-Arrival Assessment Report (PAAR) once the bank has validated the Form M documents.

How does a merchant exporter that is not the manufacturer support a Nigerian importer's NAFDAC file?

The merchant exporter's job is to source and authenticate the manufacturer's evidence pack: a valid WHO-format CoPP, a current GMP certificate, the CTD dossier, the Certificate of Analysis, samples and compliant artwork, then hand a clean, inspection-ready set to the Nigerian importer who files on NAPAMS. The Nigerian applicant files and holds the registration; the exporter de-risks it by closing dossier gaps before submission.

Are there special rules for cold-chain products like vaccines and biologics?

NAFDAC's registration guideline lists storage conditions among the minimum label requirements. We recommend a continuously monitored, documented cold chain so you can show the labelled conditions were kept in transit. This guide does not set out NAFDAC's separate storage and distribution rules for vaccines and biologics, so confirm the current requirements with the regulator before shipping.

Official sources

The regulators and official documents to check this guide against. Requirements change, so confirm the current version with the regulator before you file.

• NAFDAC: Guidelines for Registration of Imported Drug Products in Nigeria (Human and Veterinary Drugs) (PDF)
• NAFDAC: Guidelines for Renewal of Certificate of Registration for Drug Products (Human and Veterinary Drugs) (PDF)
• NAFDAC: Foreign GMP Plan
• NAFDAC: Guidelines for Clearing Imported Finished Pharmaceutical (Human and Veterinary), Nutraceuticals and Herbal Products at Ports of Entry in Nigeria (PDF)
• NAFDAC: Strategic Plan for Risk Based Inspection for Foreign Pharmaceutical Manufacturing Facilities (PDF)
• Central Bank of Nigeria: Foreign Exchange Manual, 4th Edition (PDF)
• Pharmacy Council of Nigeria: Licensing